Biopolis Biomedical Research Hub, Buona Vista, Singapore

The Biopolis in Singapore is a custom-built biomedical research and development hub at One-North, Buona Vista. Situated on 183ha, One-North will be developed over a 15-20 year period for the benefit of a range of disciplines.

The development is situated adjacent to the National University of Singapore, the Institute of Technical Education, Singapore Polytechnic, National University Hospital, Singapore Science Park, Ministry of Education and Fusionopolis (an R&D centre dedicated to electronics and technology).

The Biopolis campus was created in order to provide space for biomedical research which could promote the collaboration between private companies and public scientific / educational bodies.

Biomedical sciences (BMS) accounts for six percent of Singapore’s GDP and BMS manufacturing output is more than S$23bn.

The Biopolis development project is being undertaken by JTC Corporation (formerly Jurong Town Corporation).

Phase one and two of Singapore’s Biopolis

The Biopolis phase one development was carried out by JTC Corporation (appointed in September 2000) and required an investment of more than S$500m. The phase one complex has a cluster of seven sky-bridge connected buildings which are 8-13 storeys high. The phase one complex was opened in 2003 and has a floor space of 185,000 square metres. It houses more than 2,000 personnel.

The seven buildings are called Chromos, Helios, Centros, Genome, Matrix, Nanos and Proteos. Chromos and Helios are used by biomedical companies from the private sector and the other five buildings house public sector biomedical research agencies from the Agency for Science, Technology and Research (A*STAR).

Phase two consists of a further two seven-storey buildings, Neuros and Immunos (for research into neurology and immunology). It was opened in 2006 at a cost of $70m and offered a further 37,000 square metres of floor space.

Phases one and two have a total occupied floor space of 220,000 square metres.

Tenants of the complex include pharmaceutical companies such as GlaxoSmithKline and Novartis, as well as biotech firms SingVax and CombinatoRx. Biotech company Austrianova is located in the biopreneur lab at A*STAR’s Bioprocessing Technology Institute.

share on: